Efficacy of Oral Rabies Vaccine Baits Containing SPBN GASGAS in Domestic Dogs According to International Standards
Vaccines · 30.01.2023 · 11 (2) · 307
DOI: 10.3390/vaccines11020307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 30.01.2023. Verfasst von Katharina Bobe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Ceva Innovation Center, Am Pharmapark, (D.P.-B. formerly: Institute of Epidemiology, Friedrich-Loeffler-Institute), 06861 Dessau-Rosslau, Germany. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ceva Innovation Center GmbH.
Abstract (Originalsprache)
(1)
Background
The oral vaccination of free-roaming dogs against rabies has been developed as a promising complementary tool for mass dog vaccination. However, no oral rabies vaccine has provided efficacy data in dogs according to international standards. (2)
Methods
To test the immunogenicity and efficacy of the third-generation oral rabies virus vaccine strain, SPBN GASGAS, in domestic dogs, dogs were offered an egg-flavoured bait containing 3.0 mL of the vaccine (107.5 FFU/mL) or a placebo egg-flavoured bait. Subsequently, these 25 vaccinated and 10 control animals were challenged approximately 6 months later with a dog rabies virus isolate. Blood samples were collected at different time points postvaccination and examined by ELISA and RFFIT. (3)
Results
All but 1 of the 25 vaccinated dogs survived the challenge infection; meanwhile, all 10 control dogs succumbed to rabies. The serology results showed that all 25 vaccinated dogs seroconverted in ELISA (>40% PB); meanwhile, only 13 of the 25 vaccinated dogs tested seropositive ≥ 0.5 IU/mL) in RFFIT. (4)
Conclusions
The SPBN GASGAS rabies virus vaccine meets the efficacy requirements for live oral rabies vaccines as laid down by the European Pharmacopoeia and the WOAH Terrestrial Manual. SPBN GASGAS already fulfilled the safety requirements for oral rabies vaccines targeted at dogs. Hence, the egg-flavoured bait containing SPBN GASGAS is the first oral vaccine bait that complies with WOAH recommendations for the intended use of oral vaccination of free-roaming dogs against rabies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ceva Innovation Center, Am Pharmapark, (D.P.-B. formerly: Institute of Epidemiology, Friedrich-Loeffler-Institute), 06861 Dessau-Rosslau, Germany.
- TEW Servicegesellschaft GmbH, Am Pharmapark, (C.K. formerly: Ceva Innovation Center), 06861 Dessau-Rosslau, Germany.
- Institute of Epidemiology, Friedrich-Loeffler-Institute, 17493 Greifswald-Insel Riems, Germany.
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institute, 17493 Greifswald-Insel Riems, Germany.
ORCID-Profile: Jörn Gethmann, Conrad Freuling, Thomas Müller
Förderung
- Ceva Innovation Center GmbH
Zitieren
APA
Bobe, K., Ortmann, S., Kaiser, C., Perez-Bravo, D., Gethmann, J., Kliemt, J., Körner, S., Theuß, T., Lindner, T., Freuling, C., Müller, T., & Vos, A. (2023). Efficacy of Oral Rabies Vaccine Baits Containing SPBN GASGAS in Domestic Dogs According to International Standards. Vaccines, 11(2), 307. https://doi.org/10.3390/vaccines11020307
Vancouver
Bobe K, Ortmann S, Kaiser C, Perez-Bravo D, Gethmann J, Kliemt J, et al. Efficacy of Oral Rabies Vaccine Baits Containing SPBN GASGAS in Domestic Dogs According to International Standards. Vaccines. 2023;11(2):307. doi:10.3390/vaccines11020307
BibTeX
@article{Bobe2023,
author = {Bobe, Katharina and Ortmann, Steffen and Kaiser, Christian and Perez-Bravo, David and Gethmann, Jörn and Kliemt, Jeannette and Körner, Sophia and Theuß, Tobias and Lindner, Thomas and Freuling, Conrad and Müller, Thomas and Vos, Ad},
title = {Efficacy of Oral Rabies Vaccine Baits Containing SPBN GASGAS in Domestic Dogs According to International Standards},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {2},
pages = {307},
doi = {10.3390/vaccines11020307}
}
EUVIMED